1. Home
  2. RZLT vs DPRO Comparison

RZLT vs DPRO Comparison

Compare RZLT & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

N/A

Current Price

$2.02

Market Cap

187.3M

Sector

Health Care

ML Signal

N/A

Logo Draganfly Inc.

DPRO

Draganfly Inc.

N/A

Current Price

$6.11

Market Cap

169.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RZLT
DPRO
Founded
2010
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
187.3M
169.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RZLT
DPRO
Price
$2.02
$6.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$12.33
$15.67
AVG Volume (30 Days)
12.2M
1.4M
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,335,758.00
Revenue This Year
N/A
$56.53
Revenue Next Year
N/A
$137.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.74
52 Week Low
$1.07
$1.63
52 Week High
$11.46
$14.40

Technical Indicators

Market Signals
Indicator
RZLT
DPRO
Relative Strength Index (RSI) 25.06 38.40
Support Level $1.07 $6.26
Resistance Level $1.85 $7.70
Average True Range (ATR) 0.64 0.62
MACD -0.94 -0.08
Stochastic Oscillator 9.26 0.44

Price Performance

Historical Comparison
RZLT
DPRO

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: